You are here:
25 March 2014
GAVI-supported Pneumo and Rota studies published
Reviews highlight effectiveness of pneumococcal vaccine dosing schedule and importance of rotavirus surveillance.
28 February 2014
GAVI Alliance complements global polio eradication effort
Countries eligible for GAVI Alliance support invited to apply for funding for inactivated polio vaccine until 2015.
26 November 2013
GAVI Alliance to support Nigeria's first new national yellow fever vaccination campaign in 30 years
Mass preventive campaign will protect close to 60 million children and adults.
22 November 2013
GAVI Alliance to support introduction of inactivated polio vaccine in world’s 73 poorest countries
Alliance Board selects additional vaccines to include in its portfolio.
09 October 2013
GAVI welcomes Canada's support for measles vaccines
GAVI welcomes Canada’s US$ 20 million pledge to accelerate access to measles vaccines.
07 August 2013
At Dakar conference, countries showcase increased efforts to fund their own immunisation programs
Sabin Vaccine Institute convenes government officials to discuss progress on sustainable immunization financing programs (News release: Sabin Vaccine Institute).
26 July 2013
GAVI aims to improve access to vaccines in Nigeria through supply chains project
The GAVI Alliance has approved US$ 21 million to help improve vaccine supply chains in Nigeria as part of a partnership aimed at scaling up routine immunisation.
11 April 2013
GAVI signs-up to Polio Declaration
Scientists, doctors, experts from 75 countries highlight achievability of polio eradication
11 February 2013
Attacks on health workers in Nigeria unacceptable
The GAVI Alliance joins the World Health Organization (WHO), UNICEF and the Government of Nigeria in condemning attacks in Nigeria which have killed and injured health workers.
10 January 2013
GAVI recognised for effectiveness and focus on results
In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.
© GAVI Alliance 2014
modal window here